Skip to main content
. Author manuscript; available in PMC: 2007 Oct 22.
Published in final edited form as: Lancet. 2007 Mar 24;369(9566):1016–1026. doi: 10.1016/S0140-6736(07)60461-9

Table 2.

Dose taken by adults at withdrawal or last follow-up

Reason for withdrawal Lamotrigine Topiramate Valproate
Inadequate seizure control n=24;
341 (169),
75–600
n=3;
367 (225),
150–600
n=9;
1600 (896),
500–3000
Unacceptable adverse events n=9;
119 (99),
25–300
n=23;
172 (110),
50–500
n=13;
838 (240),
500–1200
Inadequate seizure control
and unacceptable adverse
events
n=2;
200 (0),
200–200
n=11;
177 (109),
50–400
n=8;
1325 (568),
700–2000
Other reason for withdrawal n=10;
150 (47),
50–200
n=8;
169 (53),
100–250
n=12;
958 (462),
400–2000
Remission of seizures n=5;
120 (45),
100–200
n=5;
130 (27),
100–150
n=9;
944 (336),
200–1500
Still on randomised drug n=77;
203 (101),
50–500
n=63;
171 (86),
25–400
n=72;
1081 (463),
300–3000

Data are mean (SD), range.